Healthcare merger and acquisition activity held steady in the fourth quarter of 2017. Compared with the third quarter, deal volume increased 1%, to 377 transactions. Deal volume was lower than the same quarter in 2016, down 3%. Combined spending reached $114.4 billion, up 166% compared with the $43.1 billion spent in the previous quarter, according to HealthCareMandA.com. Fourth quarter deal value was 197% higher than the $38.6 billion spent in Q4:16.

Health Care M&A Market – Deal Volume by Sector

Q4:17 Q3:17 Q4:16
Sector Deals Deals Change Deals Change
Services  
Behavioral Health Care 12 14 -14% 10 20%
Home Health & Hospice 13 12 8% 24 -46%
Hospitals 21 15 40% 23 -9%
Laboratories, MRI & Dialysis 16 15 7% 9 78%
Long-Term Care 70 74 -5% 93 -25%
Managed Care 10 8 25% 4 150%
Physician Medical Groups 32 43 -26% 28 14%
Rehabilitation 11 17 -35% 11 0%
Other 51 51 0% 45 13%
   Services subtotal 236 249 -5% 247 -4%
Technology
Biotechnology 49 42 17% 56 -13%
eHealth 30 42 -29% 30 0%
Medical Devices 28 23 22% 23 22%
Pharmaceuticals 34 17 100% 33 3%
   Technology subtotal 141 124 14% 142 -1%
Grand Total 377 373 1% 389 -3%

Source: HealthCareMandA.com, January 2018

Deal volume for the full year 2017 reached 1,566 transactions, down 2% compared with 1,593 transactions in 2016. Dollar volume was more robust, up 23% compared with 2016, to $315.3 billion.

 Healthcare services transactions made up 63% of the quarter’s deal volume, and an unusually strong 87% of the quarter’s dollar volume ($99.4 billion). The spending surge is the result of the $77 billion CVS Health/Aetna announced in early December, in the Managed Care sector. That deal alone accounted for 67% of the quarter’s total spending.

Long-Term Care remained the most active of all the sectors, although quarterly deal volume continued to slip. The 70 deals announced in the recent fourth quarter are 5% lower than the previous quarter (74 transactions). Among the services sectors, Hospitals, Laboratories/MRI/Dialysis, Rehabilitation and Other Services were the only sectors to equal or increase deal volume levels above the previous quarter.

The technology sectors showed some improvement versus the year-ago quarter, except for Biotechnology, which dipped 13%. Compared with the previous quarter, all showed higher deal volume, with the exception of eHealth (-29%).

“M&A in the fourth quarter of 2017 saw a new focus on consumerism in healthcare,” said Lisa E. Phillips, editor of HealthCareMandA.com. “The CVS Health/Aetna deal is supposed to create community health hubs. We expect to see a few more atypical match-ups like that in 2018, where acquirers look for targets in a different sector.”